Form 4 for ACH ACCENDRA HEALTH INC/VA/
Accepted 2023-11-22 00:00:00 ET · period of report 2023-11-21 · accession 0001062993-23-021402 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-22 | 2023-11-22 | ACH | Bernocchi Perry A | EVP, CEO, Patient Direct | S - Sale | $18.75 | -19.3K | 164.3K | -11% | -$361.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-22 | S | D | 19,302 | $18.75 | 164,347 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective August 11, 2023. (F2) Weighted average of the sale price range of $18.61 - $19.38. |